- 期刊
The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects
延伸閱讀
- Fireman, E., Efraimfl, S. B., Greif, J., Kivity, H. P. S., Topilsky, M., Rodrig, Y., Yellins, A., & Apte, R. N. (1994). Differential proliferative characteristics of alveolar fibroblasts in interstitial lung diseases: regulative role of IL-1 and PGE_2. Mediators of Inflammation, 1994(), 445-452. https://doi.org/10.1155/S0962935194000633
- Malaviya, A., & Sylvester, P. W. (2014). Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγAntagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells. PPAR Research, 2014(), 86-103. https://doi.org/10.1155/2014/439146
- Zhao, C., Nieves, U. M., Battista, J. A. D., Fernandes, M. J., Touaibia, M., & Bourgoin, S. G. (2015). Chemical Hypoxia Brings to Light Altered Autocrine Sphingosine-1-Phosphate Signalling in Rheumatoid Arthritis Synovial Fibroblasts. Mediators of Inflammation, 2015(), 82-93-207. https://doi.org/10.1155/2015/436525
- Hogan, C. M., Thatcher, T. H., Sapinoro, R. E., Gurell, M. N., Ferguson, H. E., Pollock, S. J., Jones, C., Phipps, R. P., & Sime, P. J. (2011). Electrophilic PPARγ Ligands Attenuate IL-1β and Silica-Induced Inflammatory Mediator Production in Human Lung Fibroblasts via a PPARγ-Independent Mechanism. PPAR Research, 2011(), 72-82. https://doi.org/10.1155/2011/318134
- He, Q., Pang, R., Song, X., Chen, J., Chen, H., Chen, B., Hu, P., & Chen, M. (2008). Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγ Dependent and Independent Mechanisms. PPAR Research, 2008(), 872-880-085. https://doi.org/10.1155/2008/649808